The Pennant Group, Inc. (NASDAQ:PNTG) Stock Rated “Moderate Buy” by Sell-Side Brokerages

Shares of The Pennant Group, Inc. (NASDAQ:PNTG) have been given a consensus rating of “Moderate Buy” by the seven analysts that are covering the firm, MarketBeat.com reports. One equities research analyst has rated the stock with a hold rating and six have given a buy rating to the company. The average 12 month price target among brokerages that have covered the stock in the last year is $42.00.

A number of research analysts have issued reports on PNTG shares. Weiss Ratings upgraded The Pennant Group from a “buy (b-)” rating to a “buy (b)” rating in a research note on Wednesday, August 19th. Royal Bank Of Canada raised their price objective on shares of The Pennant Group from $42.00 to $44.00 and gave the stock an “outperform” rating in a report on Thursday, August 20th. Wall Street Zen upgraded shares of The Pennant Group from a “hold” rating to a “buy” rating in a research note on Saturday, June 20th. Truist Financial increased their target price on shares of The Pennant Group from $42.00 to $48.00 and gave the company a “buy” rating in a research report on Tuesday, July 14th. Finally, Wells Fargo & Company lifted their price target on shares of The Pennant Group from $45.00 to $46.00 and gave the stock an “overweight” rating in a report on Tuesday, August 11th.

Institutional Trading of The Pennant Group

Several hedge funds have recently made changes to their positions in PNTG. Nykredit A S purchased a new stake in The Pennant Group in the 2nd quarter worth about $29,000. Caitong International Asset Management Co. Ltd increased its stake in shares of The Pennant Group by 154.2% in the fourth quarter. Caitong International Asset Management Co. Ltd now owns 1,182 shares of the company’s stock worth $33,000 after purchasing an additional 717 shares in the last quarter. Parallel Advisors LLC increased its stake in shares of The Pennant Group by 1,186.8% in the first quarter. Parallel Advisors LLC now owns 1,364 shares of the company’s stock worth $42,000 after purchasing an additional 1,258 shares in the last quarter. GAMMA Investing LLC raised its position in shares of The Pennant Group by 34.6% in the second quarter. GAMMA Investing LLC now owns 1,568 shares of the company’s stock valued at $58,000 after purchasing an additional 403 shares during the period. Finally, Fifth Third Bancorp lifted its stake in shares of The Pennant Group by 548.9% during the 1st quarter. Fifth Third Bancorp now owns 6,807 shares of the company’s stock valued at $207,000 after buying an additional 5,758 shares in the last quarter. 85.88% of the stock is currently owned by institutional investors.

The Pennant Group Trading Up 2.0%

NASDAQ:PNTG opened at $40.52 on Thursday. The Pennant Group has a 52 week low of $22.25 and a 52 week high of $42.74. The firm has a 50-day moving average price of $39.19 and a two-hundred day moving average price of $36.19. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.20 and a current ratio of 1.20. The firm has a market cap of $1.42 billion, a price-to-earnings ratio of 45.02, a price-to-earnings-growth ratio of 2.59 and a beta of 1.25.

The Pennant Group (NASDAQ:PNTG) last announced its earnings results on Wednesday, August 5th. The company reported $0.36 earnings per share for the quarter, topping analysts’ consensus estimates of $0.33 by $0.03. The firm had revenue of $297.98 million for the quarter, compared to the consensus estimate of $288.71 million. The Pennant Group had a return on equity of 10.33% and a net margin of 2.93%. The Pennant Group has set its FY 2026 guidance at 1.340-1.410 EPS. On average, equities analysts expect that The Pennant Group will post 1.18 earnings per share for the current fiscal year.

About The Pennant Group

The Pennant Group, Inc (NASDAQ:PNTG) is a healthcare services company that operates businesses focused on home-based care and senior living. Through its affiliated companies, Pennant provides home health, hospice and personal care services, as well as residential senior living services for older adults with varying care needs.

Its home health operations offer clinical care and rehabilitation services in patients’ homes, while its hospice businesses provide comfort-focused care and support for individuals with advanced illnesses and their families.